News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Shankar Siva: PSMA PET Sensitivity Surpasses 90% in Prostate Cancer Meta-Analysis
Shankar Siva/iconcancercentre.com.au
May 21, 2025, 08:27

Shankar Siva: PSMA PET Sensitivity Surpasses 90% in Prostate Cancer Meta-Analysis

Shankar Siva, Radiation Oncologist at Peter MacCallum Cancer Centre, shared a post on X:

“This might just be THE DEFINITIVE meta-analysis of PSMA PET for prostate cancer recurrence.
Meta-analysis of 43 studies (n=8,119)
Sensitivity from 48% at PSA 0.2–0.5 ng/ml to >90% at PSA >2.
Congrats Declan Murphy, Marlon Perera and team European Association of Urology (EAU)!”

Shankar Siva: PSMA PET Sensitivity Surpasses 90% in Prostate Cancer Meta-Analysis

Title: The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis

Authors: Elio Mazzone, Alice Thomson, David C. Chen, Donato Cannoletta, Leonardo Quarta, Antony Pellegrino, Giorgio Gandaglia, Daniel Moon, Renu Eapen, Nathan Lawrentschuk, Francesco Montorsi, Shankar Siva, Michael S. Hofman, Arturo Chiti, Alberto Briganti, Marlon L. Perera, Declan G. Murphy

Read Full Article.

PSMA PET

 Read an Article about Immunotherapy for Prostate Cancer on OncoDaily.

Alberto Briganti Alice Thomson Antony Pellegrino Arturo Chiti cancer Daniel Moon David C. Chen Declan G. Murphy Donato Cannoletta Elio Mazzone Francesco Montorsi Giorgio Gandaglia Leonardo Quarta Marlon L. Perera Michael S Hofman Nathan Lawrentschuk OncoDaily Oncology Renu Eapen Shankar Siva
Special Coverage
Science
May 21, 2025, 08:27
Shankar Siva: PSMA PET Sensitivity Surpasses 90% in Prostate Cancer Meta-Analysis
Science
May 21, 2025, 08:22
Vivek Subbiah: Cancer Treatment Paradigms in The Precision Medicine Era
Blog
May 21, 2025, 08:19
GAMPER Webinar June 2025: Radiobiological Aspects of Radiotherapy and the Potential for Hypofractionation
Blog
May 21, 2025, 08:19
Cathy Eng: Two of my earlyonset Colorectal Cancer patients were honored at this annual run in Owensboro
Blog
May 21, 2025, 08:07
Amy Comander: Honored to Volunteer at Roxbury Community Health Fair
Blog
May 21, 2025, 08:02
Catherine Alix-Panabières: Honored to Highlight Our Research on Liquid Biopsy at the CHU de Montpellier
Blog
May 21, 2025, 07:53
Helena Linardou: Last Chance to Vote for the IASLC Board Election by May 22
Blog
May 21, 2025, 07:32
Ruben Mesa: Grateful to Take On a New Role as Clinical Leader for Advocate Health’s National Cancer Program
Blog
May 21, 2025, 07:25
Benedikt Westphalen Shares Final ESMO Recommendations for Molecular Tumour Boards
Blog
May 21, 2025, 07:16
Albert Koong: A Gathering of MD Anderson Physicists Could Disturb the Force
Blog
May 21, 2025, 07:09
Daniel Sumarriva: I’m Starting a New Position as Executive Medical Director at SAGA Diagnostics
Blog
May 21, 2025, 07:01
Together, She Changed Everything: Martine Piccart’s Fight Against Breast Cancer - CancerWorld